You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Potassium Chloride 0.15% In Sodium Chloride 0.9% In Plastic Container, and when can generic versions of Potassium Chloride 0.15% In Sodium Chloride 0.9% In Plastic Container launch?

Potassium Chloride 0.15% In Sodium Chloride 0.9% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
  • What are the global sales for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
Summary for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Drug patent expirations by year for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Pharmacology for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

US Patents and Regulatory Information for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 019708-004 Sep 29, 1989 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Potassium Chloride 0.15% in Sodium Chloride 0.9% in Plastic Container

Introduction to Potassium Chloride in Sodium Chloride Solution

Potassium Chloride in 0.9% Sodium Chloride Injection is a sterile, nonpyrogenic solution used for fluid and electrolyte replenishment. It is widely utilized in medical settings to address electrolyte imbalances and provide hydration.

Market Overview

The global potassium chloride market, which includes the pharmaceutical segment, is projected to grow steadily. Here are some key insights:

  • The global potassium chloride market is estimated to be valued at approximately US$ 13,084.0 million in 2023 and is expected to reach US$ 18,102.7 million by 2033, growing at a CAGR of 3.3% during this period[1].

End-Use Industries

Pharmaceutical Industry

In the pharmaceutical sector, Potassium Chloride in 0.9% Sodium Chloride Injection is used as a source of electrolytes and water for hydration in adults and pediatric patients. It is particularly valuable for patients requiring intravenous fluid and electrolyte replenishment[2][3][4].

Clinical Use and Indications

  • This solution is indicated for use in patients needing electrolyte and fluid replenishment, especially in cases of electrolyte imbalances.
  • It is also used to induce diuresis depending on the clinical condition of the patient[4].

Market Drivers

Increasing Demand in Healthcare

The demand for potassium chloride solutions in healthcare is driven by the need for effective electrolyte replenishment and hydration. This is particularly significant in hospitals and clinical settings where patients often require intravenous fluids.

Aging Population and Chronic Conditions

The growing geriatric population and the increasing prevalence of chronic conditions that require electrolyte balance management are key drivers. Geriatric patients are at a higher risk of developing electrolyte imbalances, making this solution crucial[4].

Geographical Market Analysis

United States and China

  • The United States and China are expected to remain prominent markets for potassium chloride. These countries account for over 40% of the global market share, driven by the significant presence of end-use industries such as agriculture, pharmaceuticals, and food processing[1].

Regional Growth

  • In the United States, the market for potassium chloride is driven by its use in agriculture and pharmaceuticals. The country holds an 86.1% share in the North American market[1].
  • China’s industrial expansion, particularly in sectors like water treatment, food processing, and agriculture, is expected to boost demand for potassium chloride in the coming years[1].

Competitive Landscape

Market Consolidation and Fragmentation

  • The potassium chloride market is currently fairly consolidated, with top players holding a significant share. However, Future Market Insights expects fragmentation to increase as emerging players capitalize on market opportunities through production facility expansions and acquisitions[1].

Competition in China

  • In China, potassium chloride manufacturers face fierce competition from both local and international players. To succeed, companies need to focus on offering competitively priced products[1].

Financial Trajectory

Market Value and Growth

  • The global potassium chloride market, including the pharmaceutical segment, is expected to grow from US$ 13,084.0 million in 2023 to US$ 18,102.7 million by 2033, at a CAGR of 3.3%[1].

Revenue Streams

  • Revenue is generated through the sale of potassium chloride solutions in various concentrations, such as 0.15% Potassium Chloride in 0.9% Sodium Chloride Injection.
  • The pricing of these solutions can vary based on the concentration, volume, and packaging. For instance, a 1000 mL solution of 0.15% Potassium Chloride in 0.9% Sodium Chloride Injection is typically priced according to its formulation and packaging[2][3][4].

Challenges and Opportunities

Regulatory Compliance

  • Manufacturers must comply with stringent regulatory requirements, including storage conditions and compatibility with additives. This can be a challenge but also ensures the safety and efficacy of the product[2][3][4].

Technological Advancements

  • Advancements in technology and the availability of low-cost natural resources can facilitate market growth. For example, improvements in packaging materials and manufacturing processes can enhance product quality and reduce costs[1].

Adverse Reactions and Safety Considerations

  • The use of Potassium Chloride in Sodium Chloride Injection can lead to adverse reactions such as hyperkalemia, fluid overload, and hypersensitivity reactions. Therefore, careful dose selection and monitoring, especially in geriatric patients, are crucial[4].

Storage and Handling

  • The solution must be stored at room temperature, protected from excessive heat and freezing. Any container suspected of damage or leakage should be discarded to ensure safety[2][3][4].

Key Takeaways

  • The potassium chloride market, including the pharmaceutical segment, is expected to grow steadily driven by increasing demand in healthcare and industrial expansion.
  • The United States and China are key markets due to their significant end-use industries.
  • The market is currently consolidated but is expected to see increased fragmentation.
  • Regulatory compliance and technological advancements are critical for market growth.
  • Careful handling and storage are essential to ensure product safety.

FAQs

1. What is the primary use of Potassium Chloride in 0.9% Sodium Chloride Injection?

The primary use is as a source of electrolytes and water for hydration in adults and pediatric patients, particularly for intravenous fluid and electrolyte replenishment.

2. Which regions are expected to dominate the potassium chloride market?

The United States and China are expected to remain prominent markets, accounting for over 40% of the global market share.

3. What are the potential adverse reactions associated with Potassium Chloride in Sodium Chloride Injection?

Potential adverse reactions include hyperkalemia, fluid overload, hypersensitivity reactions, and cardiac disorders such as cardiac arrest.

4. How should Potassium Chloride in Sodium Chloride Injection be stored?

The solution should be stored at room temperature, protected from excessive heat and freezing, and any damaged or leaking containers should be discarded.

5. What is the projected growth rate of the global potassium chloride market from 2023 to 2033?

The global potassium chloride market is expected to grow at a CAGR of 3.3% from 2023 to 2033.

Cited Sources:

  1. Future Market Insights, "Potassium Chloride Market Size, Growth, Trend & Share | 2033"
  2. DailyMed, "Potassium Chloride in 0.9% Sodium Chloride Injection"
  3. Baxter Corporation, "Potassium Chloride in 0.9% Sodium Chloride Injection, USP Prescribing Information"
  4. Drugs.com, "Potassium Chloride in Sodium Chloride: Package Insert"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.